Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: UNH stock price vs ROST: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ROST's multiple
Needs ROST P/E.
Implied fair value · at UNH's multiple
Needs UNH P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
UnitedHealth Group Incorporated · implied price per share
Bear
$222.49
Base
$271.41
Bull
$335.10
Ross Stores, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
HUMANA INC
UNH vs HUM
CENTENE CORP
UNH vs CNC
CVS Health Corporation
UNH vs CVS
Elevance Health, Inc.
UNH vs ELV
MOLINA HEALTHCARE, INC.
UNH vs MOH
TJX COMPANIES INC /DE/
UNH vs TJX
Walgreens Boots Alliance, Inc.
UNH vs WBA
NORDSTROM INC
UNH vs JWN
Macy's, Inc.
UNH vs M
DILLARD'S, INC.
UNH vs DDS
TARGET CORP
UNH vs TGT
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe UNH can sustain double-digit revenue growth while improving its thin operating and net margins, then the stock can be justified on a relative valuation basis; otherwise, the current price already sits near the top of its historical range and the case for clear upside is weaker.
UNH trades at $407.08 versus a ROST-implied price of $510.85, implying 25.5% upside on this framework. The gap is driven by UNH’s lower multiples versus ROST on EV/Revenue and EV/EBITDA, even though UNH also has a lower P/E.
Supporting Metrics
